These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3577740)

  • 21. Effects of Resveratrol Supplementation on  Methotrexate Chemotherapy-Induced Bone Loss.
    Lee AM; Shandala T; Soo PP; Su YW; King TJ; Chen KM; Howe PR; Xian CJ
    Nutrients; 2017 Mar; 9(3):. PubMed ID: 28282956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimentally induced heterotopic ossification in rats influenced by anti-inflammatory drugs.
    Törnkvist H; Nilsson OS; Bauer FC; Lindholm TS
    Scand J Rheumatol; 1983; 12(2):177-80. PubMed ID: 6407100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High doses of the diphosphonate EHDP for the prevention of heterotopic ossification. An experimental and clinical study.
    Lindholm TS; Bauer FC; Rindell K
    Scand J Rheumatol; 1987; 16(1):33-9. PubMed ID: 3109023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcitonin inhibits heterotopic bone formation in rats.
    Günal I; Eren A; Gürer F; Seber S
    Int J Tissue React; 1995; 17(2):87-91. PubMed ID: 8847185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The osteo-inductive properties of bone matrix from rats pretreated with indomethacin.
    Törnkvist H; Bauer FC; Lindholm TS; Nilsson OS
    Scand J Rheumatol; 1985; 14(2):197-200. PubMed ID: 4001892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of bupivacaine on muscle tissues and new bone formation induced by demineralized bone matrix gelatin.
    Yamashita K; Horisaka Y; Okamoto Y; Yoshimura Y; Matsumoto N; Kawada J; Takagi T
    Acta Anat (Basel); 1991; 141(1):1-7. PubMed ID: 1835237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterotopic new bone formation causes resorption of the inductive bone matrix.
    Nilsson OS; Persson PE; Ekelund A
    Clin Orthop Relat Res; 1990 Aug; (257):280-5. PubMed ID: 2379365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone induction by AdBMP-2/collagen implants.
    Schreiber RE; Blease K; Ambrosio A; Amburn E; Sosnowski B; Sampath TK
    J Bone Joint Surg Am; 2005 May; 87(5):1059-68. PubMed ID: 15866970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indomethacin inhibits bone formation in inductive allografts but not in autografts: studies in rat.
    Persson PE; Sisask G; Nilsson O
    Acta Orthop; 2005 Aug; 76(4):465-9. PubMed ID: 16195059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats.
    May KP; West SG; McDermott MT; Huffer WE
    Arthritis Rheum; 1994 Feb; 37(2):201-6. PubMed ID: 8129775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of acetylsalicylic acid on heterotopic bone resorption and formation in rats.
    Solheim LF; Rönningen H; Langeland N
    Arch Orthop Trauma Surg (1978); 1986; 105(3):142-5. PubMed ID: 3527107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of fibrin sealant on demineralized bone matrix-dependent osteoinduction. A quantitative and qualitative study in rats.
    Schwarz N; Redl H; Schlag G; Schiesser A; Lintner F; Dinges HP; Thurnher M
    Clin Orthop Relat Res; 1989 Jan; (238):282-7. PubMed ID: 2463128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration.
    Bauss F; Lang K; Dony C; Kling L
    Growth Horm IGF Res; 2001 Feb; 11(1):1-9. PubMed ID: 11437468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of indomethacin and diclofenac in the inhibition of experimental heterotopic new bone formation.
    Nilsson OS; Bauer HC; Brosjö O; Törnkvist H
    Int Orthop; 1987; 11(3):283-7. PubMed ID: 3623768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delivery of demineralized bone powder by fibrin sealant.
    Lasa C; Hollinger J; Drohan W; MacPhee M
    Plast Reconstr Surg; 1995 Nov; 96(6):1409-17; discussion 1418. PubMed ID: 7480241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone formation enhanced by induction. Bone growth in titanium implants in rats.
    Rønningen H; Solheim LF; Langeland N
    Acta Orthop Scand; 1985 Feb; 56(1):67-71. PubMed ID: 3885673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone induction by BMPs/OPs and related family members in primates.
    Ripamonti U; Ramoshebi LN; Matsaba T; Tasker J; Crooks J; Teare J
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S116-27. PubMed ID: 11314789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-dependent stimulation of bone induction by basic fibroblast growth factor in rats.
    Aspenberg P; Thorngren KG; Lohmander LS
    Acta Orthop Scand; 1991 Oct; 62(5):481-4. PubMed ID: 1835244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cyclosporin A on bone turnover and on resorption of demineralized bone matrix.
    Ekelund AL; Nilsson O
    Clin Orthop Relat Res; 1996 May; (326):127-34. PubMed ID: 8620633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone-targeted methotrexate-alendronate conjugate inhibits osteoclastogenesis in vitro and prevents bone loss and inflammation of collagen-induced arthritis in vivo.
    Xie Z; Liu G; Tang P; Sun X; Chen S; Qin A; Zhu P; Zhang J; Fan S
    Drug Deliv; 2018 Nov; 25(1):187-197. PubMed ID: 29303005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.